These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449 [TBL] [Abstract][Full Text] [Related]
5. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults. Chen M; Ssali F; Mulungi M; Awio P; Yoshimine H; Kuroki R; Furumoto A; Tanimura S; Kityo C; Nagatake T; Mugyenyi P; Oishi K Vaccine; 2008 Sep; 26(38):4962-8. PubMed ID: 18639599 [TBL] [Abstract][Full Text] [Related]
6. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity. Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [TBL] [Abstract][Full Text] [Related]
8. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease. Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319 [TBL] [Abstract][Full Text] [Related]
9. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants. Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H; Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [TBL] [Abstract][Full Text] [Related]
12. Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials. Jahn-Eimermacher A; du Prel JB; Schmitt HJ Vaccine; 2007 Aug; 25(33):6237-44. PubMed ID: 17629378 [TBL] [Abstract][Full Text] [Related]
13. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Hak E; Grobbee DE; Sanders EA; Verheij TJ; Bolkenbaas M; Huijts SM; Gruber WC; Tansey S; McDonough A; Thoma B; Patterson S; van Alphen AJ; Bonten MJ Neth J Med; 2008 Oct; 66(9):378-83. PubMed ID: 18990781 [TBL] [Abstract][Full Text] [Related]
14. No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults. Viard JP; Assuied A; Lévy Y; Souberbielle JC; Thiébaut R; Carrat F; Chêne G; Launay O; Richert L PLoS One; 2016; 11(12):e0168640. PubMed ID: 27977797 [TBL] [Abstract][Full Text] [Related]
15. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials. Kong L; Kohberger RC; Koch GG J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971 [TBL] [Abstract][Full Text] [Related]
16. Sequential monitoring of clinical trials with multiple survival endpoints. Williams PL Stat Med; 1996 Nov 15-30; 15(21-22):2341-57; discussion 2367-70. PubMed ID: 8931205 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744 [TBL] [Abstract][Full Text] [Related]
18. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae. Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518 [TBL] [Abstract][Full Text] [Related]
19. Quality control and the identification of vaccine responders using ELISA-derived antibody data. Le CT; Grambsch PM; Giebink GS Stat Med; 2003 Sep; 22(18):2935-42. PubMed ID: 12953289 [TBL] [Abstract][Full Text] [Related]
20. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]